Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 4 min ago
Peer-reviewedCC BY 4.0Nucleic Acids Research

Notch/NF-κB crosstalk signaling controls SASP gene expression during brain aging

1 more authors
4 affiliations
  1. 1University Hospital Ulm, Department of Internal Medicine I , Albert-Einstein-Allee 23, 89081 Ulm ,
  2. 2Department of Neurology, The Affiliated Suzhou Hospital of Nanjing Medical University , Suzhou 215002 ,
  3. 3University of Ulm, Institute for Physiological Chemistry , Albert-Einstein-Allee 11, 89081 Ulm ,
  4. 4Justus-Liebig-University Giessen, Institute of Biochemistry , Friedrichstrasse 24, 35392 Giessen ,

Abstract

Brain aging is associated with chronic, low-grade inflammation known as inflammaging, which is largely driven by senescent glial cells secreting pro-inflammatory factors termed as senescence-associated secretory phenotype (SASP). In humans, the release of SASP factors in the brain is linked with an increased risk for the development of neurodegenerative disorders; thus, elucidating the underlying molecular mechanisms is essential for understanding the pathophysiology of brain aging. Both NF-κB and Notch signaling are known to regulate SASP expression; however, their mode of interaction in brain inflammaging is poorly understood. Here, we demonstrate that brain aging is broadly associated with NF-κB activation but Notch suppression using different transgenic mouse models. Astrocytic NF-κB activation in young mice was able to mimic premature SASP formation but repressed Notch signaling in parallel. Bioinformatic analyses further identified conserved crosstalk sites within SASP genes co-occupied by Notch/RBPJ and NF-κB transcription factors in vivo, allowing specific combinatorial regulation. Importantly, selective physical interactions enable that activated Notch can act as a negative modulator of NF-κB signaling at different molecular levels. Consistently, pharmacological activation of Notch in primary astrocytes significantly reduced NF-κB-driven SASP gene expression. Together, these findings identify Notch–NF-κB crosstalk as a potential therapeutic target to mitigate brain inflammaging.

Related

  1. Spatial, temporal and Notch determination of terminal selector expression controls neuronal cell fate in the Drosophila optic lobe
    Félix Simon, Isabel Holguera, Yen-Chung Chen +9
    Nature NeurosciencePeer-reviewedCC BY 4.0Full text7 citedProteomics & metabolomicsNeuroscienceHAL
  2. Notch Signalling Controls Differential Proliferation During Rotation and Asymmetric Morphogenesis of Mouse Incisors
    Argyro Lamprou, Cristina Porcheri, Thimios A. Mitsiadis
    CellsPeer-reviewedCC BY 4.0Molecular biology & gene regulationCrossref
  3. Exploratory analysis of Notch and Wnt pathway gene expression across biofluids and tumor tissue in gynecologic cancer
    Ieva Vaicekauskaitė, Paulina Kazlauskaitė, Diana Žilovič +2
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textMolecular biology & gene regulationCrossref
  4. A SIRT1-LSD1 Corepressor Complex Regulates Notch Target Gene Expression and Development
    Peter Mulligan, Fajun Yang, Luisa Di Stefano +12
    Molecular CellPeer-reviewedLicence not statedFull text211 citedMolecular biology & gene regulationHAL
  5. The C. elegans endoplasmic reticulum molecular chaperone ENPL-1 does not promote GLP-1/Notch signaling
    James L. Lissemore, Amanda Pancake, Shurong Fang +1
    microPublication BiologyPeer-reviewedCC BYFull textMolecular biology & gene regulationDOAJ
BibTeX
@article{yang2026notchnfκb,
  title = {{Notch/NF-κB crosstalk signaling controls SASP gene expression during brain aging}},
  author = {Qingwen Yang and Hina Zarrin and Tabea Hein and Burak Yildiz and Vivien Prex and Konstantinos Siontas and Tilman Borggrefe and Benedetto Daniele Giaimo and Tobias Friedrich and M Lienhard Schmitz and Thomas Wirth and Franz Oswald and Bernd Baumann},
  journal = {Nucleic Acids Research},
  year = {2026},
  month = nov,
  doi = {10.1093/nar/gkag1110},
  url = {https://academic.oup.com/nar/article/doi/10.1093/nar/gkag1110/9013032},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Notch/NF-κB crosstalk signaling controls SASP gene expression during brain aging
AU  - Qingwen Yang
AU  - Hina Zarrin
AU  - Tabea Hein
AU  - Burak Yildiz
AU  - Vivien Prex
AU  - Konstantinos Siontas
AU  - Tilman Borggrefe
AU  - Benedetto Daniele Giaimo
AU  - Tobias Friedrich
AU  - M Lienhard Schmitz
AU  - Thomas Wirth
AU  - Franz Oswald
AU  - Bernd Baumann
PY  - 2026
DA  - 2026/11/05
JO  - Nucleic Acids Research
DO  - 10.1093/nar/gkag1110
UR  - https://academic.oup.com/nar/article/doi/10.1093/nar/gkag1110/9013032
AB  - Brain aging is associated with chronic, low-grade inflammation known as inflammaging, which is largely driven by senescent glial cells secreting pro-inflammatory factors termed as senescence-associated secretory phenotype (SASP). In humans, the release of SASP factors in the brain is linked with an increased risk for the development of neurodegenerative disorders; thus, elucidating the underlying molecular mechanisms is essential for understanding the pathophysiology of brain aging. Both NF-κB and Notch signaling are known to regulate SASP expression; however, their mode of interaction in brain inflammaging is poorly understood. Here, we demonstrate that brain aging is broadly associated with NF-κB activation but Notch suppression using different transgenic mouse models. Astrocytic NF-κB activation in young mice was able to mimic premature SASP formation but repressed Notch signaling in parallel. Bioinformatic analyses further identified conserved crosstalk sites within SASP genes co-occupied by Notch/RBPJ and NF-κB transcription factors in vivo, allowing specific combinatorial regulation. Importantly, selective physical interactions enable that activated Notch can act as a negative modulator of NF-κB signaling at different molecular levels. Consistently, pharmacological activation of Notch in primary astrocytes significantly reduced NF-κB-driven SASP gene expression. Together, these findings identify Notch–NF-κB crosstalk as a potential therapeutic target to mitigate brain inflammaging.
SN  - 0305-1048
SN  - 1362-4962
ER  -